2025
SJR Q3
JCR Q2 · 2,6
47 matched articles
SCIE
Journal detail
Current Radiopharmaceuticals
- Publisher
- KeAi Communications Co.
- Country
- United Arab Emirates · Middle East
- Type
- journal
- ISSN
-
1874471018744729
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,394
- Quartile Q3
- H-Index 37
- Cites/doc 2,17
- Docs (3y) 113
- Cites (3y) 211
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,6
- 5Y JIF 2,1
- JCI 0,59
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q3
- Radiology, Nuclear Medicine and Imaging Q3
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy | Radiology, Nuclear Medicine & Medical Imaging
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q2 | 0,394 | 2,6 | 2,1 | 0,59 | Q3 | 37 |
| 2024 | Q3 | Q4 | 0,297 | 1,2 | 1,6 | 0,37 | Q3 | 35 |
| 2023 | Q2 | Q3 | 0,542 | 1,5 | 2,3 | 0,48 | Q3 | 35 |
| 2022 | Q3 | Q3 | 0,379 | 2,3 | 2,1 | 0,46 | Q3 | 35 |
| 2021 | Q2 | Q4 | 0,587 | 2 | 2,5 | 0,64 | Q2 | 35 |
| 2020 | Q2 | — | 0,586 | — | — | 0,53 | Q3 | 35 |
| 2019 | Q3 | — | 0,447 | — | — | — | — | 35 |
| 2017 | Q3 | — | 0,389 | — | — | — | — | 35 |
| 2016 | Q3 | — | 0,453 | — | — | — | — | 35 |
| 2015 | Q3 | — | 0,323 | — | — | — | — | 35 |
| 2014 | Q2 | — | 0,589 | — | — | — | — | 35 |
| 2013 | Q2 | — | 0,555 | — | — | — | — | 35 |
| 2012 | Q3 | — | 0,392 | — | — | — | — | 35 |
| 2011 | Q3 | — | 0,226 | — | — | — | — | 35 |
| 2010 | Q3 | — | 0,245 | — | — | — | — | 35 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 195/356 |
| 2025 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q2 | Q3 | 92/217 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 291/352 |
| 2024 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | Q3 | 163/213 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 265/354 |
| 2023 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | Q3 | 124/204 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 200/278 |
| 2022 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q3 | Q3 | 83/135 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 235/279 |
| 2021 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SCIE | Q4 | Q2 | 105/136 |
| 2020 | PHARMACOLOGY & PHARMACY | ESCI | — | Q3 | — |